 BIND-014 docetaxel nanoparticles for injectable suspension is being studied in patients with v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog KRAS mutation positive or squamous cell non-small cell lung cancer NSCLC who have progressed after treatment of one prior platinum-containing chemotherapy regimen. 